Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shintaro Saito"'
Autor:
Zhuoqing Chen, Kenichi Nakajima, Ken-ichi Hirano, Takashi Kamiya, Shohei Yoshida, Shintaro Saito, Seigo Kinuya
Publikováno v:
Annals of Nuclear Medicine. 36:986-997
Objective This study aimed to optimize various methods of calculating washout rates (WRs) of 123I-β-methyl-p-iodophenyl-pentadecanoic (BMIPP), as they are essential to diagnose triglyceride deposit cardiomyovasculopathy (TGCV) which is a rare diseas
Autor:
Kenichi Nakajima, Shintaro Saito, Zhuoqing Chen, Junji Komatsu, Koji Maruyama, Naoki Shirasaki, Satoru Watanabe, Anri Inaki, Kenjiro Ono, Seigo Kinuya
Publikováno v:
Annals of Nuclear Medicine. 36:765-776
Objectives 123I-ioflupane has been clinically applied to dopamine transporter imaging and visual interpretation assisted by region-of-interest (ROI)-based parameters. We aimed to build a multivariable model incorporating machine learning (ML) that co
Autor:
Seigo Kinuya, Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Shintaro Saito, Anri Inaki, Yuji Kunita, Takafumi Yamase, Satoru Watanabe, Norihito Akatani, Daiki Kayano
Publikováno v:
Annals of Nuclear Medicine. 36:61-69
OBJECTIVE Given the rarity of refractory pheochromocytoma and paraganglioma (PPGL), outcomes and prognostic factors after 131I-metaiodobenzylguanidine (131I-mIBG) treatment still remain unclear. Therefore, this study evaluated whether baseline charac
Publikováno v:
Annals of Nuclear Medicine. 35:649-661
To evaluate the detecting capability between planar imaging (PI) and PI combined with single-photon emission computed tomography/computed tomography (PICWS), including 123I- and 131I-labeled metaiodobenzylguanidine (mIBG) and to compare the detecting
Autor:
Hiroshi Mori, Rie Kuroda, Raita Araki, Seigo Kinuya, Taizo Wada, Anri Inaki, Takafumi Yamase, Satoru Watanabe, Toshihiro Fujiki, Norihito Akatani, Shintaro Saito, Ryosei Nishimura, Hiroshi Wakabayashi, Yuji Kunita, Yasuhiro Ikawa, Tomo Hiromasa, Daiki Kayano
Publikováno v:
Annals of Nuclear Medicine. 34:840-846
Children with relapsed neuroblastoma have a poor prognosis despite modern multimodality therapy. Novel and more effective therapeutic strategies are required for relapsed neuroblastoma. We retrospectively examined the utility of consolidation therapy